top of page

Our Strategy

We accompany inventors in the drug development journey: from innovative scientific ideas towards the medicines of tomorrow

Our comprehensive approach de-risks investments for our partners 

Providing management and operational support as an incubator, we maximize funding resources toward project maturation

We create a roadmap for the selected projects to mature towards proof-of-concept and commercialization: start-up creation or out-licencing

What we do

We look for life science projects from academia or early-stage biotech companies focused on aging and neurodegeneration

We synergize with scientists on a jointly defined project development plan to financially support, steer and accelerate the selected breakthrough proposals

We commercialize successful projects by creating spin-off companies or out-licensing to Pharma partners

What we are looking for

Innovative early-stage projects from universities, research institutions or biotech companies

Novel drug discovery projects, diagnostic methods, disease biomarkers or novel imaging approaches that focus on neurodegenerative diseases

Novel biomarkers and products that aim to increase healthspan by targeting the molecular and cellular mechanisms of aging

Projects with significant commercial potential

Strong IP position (recently filed or potential for new IP)

Collaborative and positive team spirit

Our selection process

Tell us about your project: are you a researcher or technology transfer officer? Send us an email or fill out this short application form describing your project.  

After an initial assessment, we will give you timely feedback, which may lead to further discussions, analysis of developmental feasibility, commercial potential, and intellectual property position

Selected projects will enter the acceleration phase, where each will receive financing (of up to ~€1M) to achieve proof-of-concept within an average of 9 to 12 months 

Projects that meet the defined milestones and success criteria are commercialized by CEBINA either through spin-out company formation or out-licensing 

The newly incorporated company is managed and supported by the flexible CEBINA model to achieve its strategic goals 

bottom of page